The Japan Society of Drug Delivery System, The Japan Society of Drug Delivery System Young Investigator's awardHiroto Hatakeyama
Mar 2017
The Pharmaceutical Society of Japan, The Pharmaceutical Society of Japan Award for Young Scientists,Development of a novel liposomal DDS by manipulating pharmacokinetics and intracellular trafficking for drug therapy and nucleic acid medicineHiroto Hatakeyama
RNA vaccines are applicable to the treatment of various infectious diseases via the inducement of robust immune responses against target antigens by expressing antigen proteins in the human body. The delivery of messenger RNA by lipid nanoparticle...
RNA vaccines based on Lipid nanoparticles (LNP) were put into practical use within only one year after the global outbreak of the coronavirus disease 2019 (COVID-19). This success of RNA vaccine highlights the utility of an mRNA delivery system as...
Because of its efficient and robust gene transfer capability, messenger RNA (mRNA) has become a promising tool in various research fields. The lipid nanoparticle (LNP) is considered to be a fundamental technology for an mRNA delivery system and ha...
Small (Weinheim an der Bergstrasse, Germany) e2205131 Jan 2023 [Refereed]
The reactivation of anticancer immunity is a fundamental principle in cancer immunotherapy as evidenced by the use of immune checkpoint inhibitors (ICIs). While treatment with the ICIs is shown to have remarkable and durable therapeutic effects in...
Khalil IA, Hatakeyama H, Nakamura T, Harashima H(Part:Contributor, A Multifunctional Envelope-type Nano Device for Cancer Therapy)
Springer 2019 (ISBN:9784431568803) [Refereed]
This book proposes the importance of new systems of drug design and delivery based on cancer pathophysiology in addition to cancer molecular and cellular biology. The current studies based on molecular and cellular biology while ignoring pathophys...
○○学科